TSX:WELL

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

Retrieved on: 
Thursday, May 16, 2024
AJKD, Statistics, Patient, First officer (aviation), Health, Conditional sentence, National Kidney Foundation, Electronic health record, Nephrology, AI, Chronic kidney disease, Death, CKD, American Journal, Statistics Canada, WELL, AIDX, Kidney, Physician, Disability, Guideline, TSX, Medical device

In Canada alone, the economic burden of chronic and end-stage kidney disease costs the national healthcare system more than $40 billion per year.

Key Points: 
  • In Canada alone, the economic burden of chronic and end-stage kidney disease costs the national healthcare system more than $40 billion per year.
  • HEALWELL’s recently launched second-generation AI Clinical Co-Pilot incorporates similar advanced technology to support physicians with improved patient care.
  • This highlights how HEALWELL’s technology can support US specialists in one of the most important chronic disease domains; chronic kidney disease.
  • In Canada alone, the economic burden of chronic and end-stage kidney disease costs the national healthcare system more than $40 billion(2) per year.

Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities

Retrieved on: 
Wednesday, May 15, 2024
Partnership, Electron, News, Artificial intelligence in healthcare, Photon, AIDX, TSX, Medicine, Language, PALM, Veeva Systems, Natural language processing, GLM, NLP, WELL, Behavior, Risk assessment, Toronto Stock Exchange, USD, Health, Yoy, OTCQX, Public, Statista, NVDA, NPS, OTCQB, Nvidia, Offering, QPU, Patient, Computer, JSC, Treatment, AI, Growth, NVIDIA, Data analysis, Roger Hawkins (drummer), Medical device

MarketsAndMarkets continued: “Natural Language Processing (NLP) in healthcare enables computers to analyze, generate, and translate human language.

Key Points: 
  • MarketsAndMarkets continued: “Natural Language Processing (NLP) in healthcare enables computers to analyze, generate, and translate human language.
  • It unlocks insights from unstructured data, streamlines tasks, empowers patients through chatbots, and enhances personalized medicine, revolutionizing healthcare delivery.
  • Natural Language Processing (NLP) plays a pivotal role in revolutionizing patient data analysis and risk assessment within AI in healthcare.
  • Generating extensive and intricate healthcare datasets is a pivotal driver for AI in the healthcare Market.

HEALWELL AI Provides Corporate Update and Preliminary Financial Results for the Year Ended December 31, 2023

Retrieved on: 
Thursday, March 21, 2024
The Company, Software as a service, Data science, Partnership, Health, Acquisition, WELL, Bank statement, TSX, EHR, WELL Health Technologies, Hand, AIDX, Medical device

HEALWELL AI to hold a conference call and simultaneous webcast next week, details will be provided separately when they are available.

Key Points: 
  • HEALWELL AI to hold a conference call and simultaneous webcast next week, details will be provided separately when they are available.
  • TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to provide a corporate update including the release of preliminary financial results for its Fiscal Fourth Quarter and Year Ended December 31, 2023.
  • Selected unaudited financial result expectations for the periods include:
    Annual revenue from continuing operations of $7.32 million during fiscal 2023.
  • HEALWELL will release its financial results for the Year Ended December 31, 2023 next week.

HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI-Based Preventative Care Solutions to U.S. Market

Retrieved on: 
Thursday, March 14, 2024
Diagnosis, CRH, Algorithm, Partnership, Risk, EMR, Patient, SAN, Artificial intelligence, AI, WELL, Inflammatory bowel disease, IBD, TSX, OTCQX, Clinical trial, Strategic alliance, AIDX, Medical device

HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions.

Key Points: 
  • HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions.
  • HEALWELL’s Khure Health will integrate its proprietary AI platform with Circle Medical’s electronic medical record system, expanding its footprint to over 30 US states.
  • Enabling WELL USA and Circle Medical providers is a demonstration of this commitment and a major step forward for HEAWELL into the US market.
  • George Favvas, CEO of Circle Medical commented, “We are excited to partner with Khure and bring their AI solutions to the healthcare practitioners we support.

WELL Health Founder & CEO Hamed Shahbazi Appointed Chairman of the Board of HEALWELL AI

Retrieved on: 
Tuesday, February 27, 2024
PayPal, AI, AIDX, Class, Physician, Quality of life, TSX, Growth, Conditional sentence, TIO, WELL, Patient, Diagnosis, OTCQX, WELL Health Technologies, Face, Software, Management

Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care.

Key Points: 
  • Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care.
  • Mr. Hamed Shahbazi is currently the Chairman and CEO of WELL, Canada's largest owner operator of outpatient medical clinics and leading digital health service providing software and services to more than one third of all Canadian physicians.
  • Mr. Shahbazi has served on the Board of HEALWELL since its launch on October 1, 2023.
  • Hamed Shahbazi, Founder and CEO of WELL commented on his appointment, “As a co-founder of HEALWELL, I am personally very proud and excited to take on the role of Chairman for HEALWELL AI given the enormous importance of the shared mission and objective we have between WELL and HEALWELL.

HEALWELL AI Completes Acquisition of Intrahealth

Retrieved on: 
Thursday, February 1, 2024
AIDX, Intelligence, OTCQX, EHR, Growth, VBC, Electronic health record, Patient, Transaction, TSX, WELL, Acquisition, Case management, Health, Software as a service, Ambulatory care, Hospital, Medical device

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce it has completed the previously announced acquisition of Intrahealth Systems Limited (“Intrahealth”), a former subsidiary of WELL Health Technologies Corp. (“WELL”) (TSX: WELL), which is an insider of the Company (the “Transaction”).

Key Points: 
  • TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX, OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce it has completed the previously announced acquisition of Intrahealth Systems Limited (“Intrahealth”), a former subsidiary of WELL Health Technologies Corp. (“WELL”) (TSX: WELL), which is an insider of the Company (the “Transaction”).
  • Dr. Alexander Dobranowski, CEO of HEALWELL, commented on the acquisition, “We are pleased to complete the acquisition of Intrahealth and excited to welcome the Intrahealth team to HEALWELL.
  • Dorian Prior, President of Intrahealth commented, “We are thrilled to join forces with HEALWELL, a trailblazer in AI technology, and excited with the potential of integrating our products with HEALWELL’s cutting-edge AI technologies.
  • As part of the Transaction, HEALWELL, WELL and Intrahealth entered into a Transition Services Agreement to ensure a timely and efficient transition of the services of Intrahealth to HEALWELL.

HEALWELL AI to Acquire Intrahealth to Create Next Generation AI Powered EHR

Retrieved on: 
Friday, January 26, 2024
VBC, Patient, Hospital, Transaction, Person, Software as a service, Class, AI, Case management, Electronic health record, Growth, TSX, Acquisition, Minority, AIDX, WELL, Health, OTCQX, Ambulatory care, EHR, Security (finance)

Intrahealth is expected to generate over $12 million in revenues in 2024, which reflects double digit organic growth.

Key Points: 
  • Intrahealth is expected to generate over $12 million in revenues in 2024, which reflects double digit organic growth.
  • HEALWELL’s plan is to deeply integrate its industry leading AI tools with Intrahealth and help create a next generation AI Powered EHR to help significantly amplify healthcare providers and allow them to drive better health outcomes at lower costs in a manner aligned with global Value Based Care (VBC) trends.
  • Intrahealth is an advanced SaaS-based Electronic Health Records (“EHR”) management platform for small and medium enterprise healthcare organizations across Canada, Australia, and New Zealand.
  • EHR systems that are not outfitted with AI capabilities either natively or through an AI powered clinical decision support system will not be able to retain their customers in the future.

HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company

Retrieved on: 
Monday, December 4, 2023
Entrepreneurship, Family, Partnership, Pedigree, Research, Acquisition, Hospital, AIDX, WELL, AI, Artificial intelligence in healthcare, TSX, Patient, Publication, Automation, History, RWE, Data science, Medical device

HEALWELL completes acquisition of a majority stake of Pentavere, a healthcare artificial intelligence (AI) company who has built a best-in-class AI engine to help solve some of healthcare’s toughest data challenges.

Key Points: 
  • HEALWELL completes acquisition of a majority stake of Pentavere, a healthcare artificial intelligence (AI) company who has built a best-in-class AI engine to help solve some of healthcare’s toughest data challenges.
  • The Pentavere acquisition adds revenue, new pharmaceutical and life sciences customers, access to hospitals as well as growing HEALWELL’s dedicated team of AI engineers.
  • Dr. Alexander Dobranowski, CEO of HEALWELL, commented on the acquisition, “We are thrilled to welcome Pentavere to the HEALWELL family.
  • This marks our first acquisition in the healthcare technology space, signifying a pivotal moment in HEALWELL history.

HEALWELL to Acquire Control of AI Leader ‘Pentavere’ to Help Solve Some of Healthcare’s Toughest Data Challenges

Retrieved on: 
Wednesday, November 15, 2023
Acquisition, Research, Entrepreneurship, Artificial intelligence in healthcare, Data science, Doc, Treasury, Literature, History, Patient, WELL, Internal Medicine Journal, Intelligence, Internal medicine, AIDX, Hierarchy, Pedigree, Partnership, Health care, Digitization, Health, Hospital, AI, Family, VWAP, TSX, White paper, IDC, Publication, RWE, Medical device, Nursing, The Pentaverate

The Pentavere acquisition adds revenue, new pharma customers and access to hospitals as well as growing HEALWELL’s dedicated team of AI engineers.

Key Points: 
  • The Pentavere acquisition adds revenue, new pharma customers and access to hospitals as well as growing HEALWELL’s dedicated team of AI engineers.
  • Pentavere has a proven track record in commercialization of real-world evidence studies and has developed strong partnerships with major hospital networks.
  • Dr. Alexander Dobranowski, CEO of HEALWELL commented, “We are thrilled at the prospect of welcoming Pentavere, a real AI powerhouse, to the HEALWELL family.
  • This proposed acquisition will represent a major leap forward in our mission to revolutionize healthcare through the use of AI and data science.